Alleged Insider Trader Sues For Fees In Del. Bioverativ Suit
A former board member of Bioverativ Inc., a hemophilia-focused biopharm that Sanofi SA bought in 2018, has sued both companies in Delaware Chancery Court, alleging they have refused to pay his...To view the full article, register now.
Already a subscriber? Click here to view full article